ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:06 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 34
Drug details and screening numbers
Drug Name: Imatinib
Drug ID: 34
Synonyms: STI-571
Brand name: Gleevec
Target: ABL, KIT, PDGFR
Number of cell lines screened: 409
Screening concentration range(s): 0.0078125 to 2 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a7 |
BCR-ABL_mut |
34 |
1 |
1 |
Imatinib |
ABL, KIT, PDGFR |
5 |
403 |
0.693 |
2.79 |
-1.31 |
-4.1 |
4.2 ** |
4.3 ** |
1.9 * |
1.12e-14 |
1.9e-11 |
5.32e-01 |
2.6e-08 |
All-tests volcano plot